Total Payments
$3,796
2024 Payments
$883.69
Companies
18
Transactions
140
Medicare Patients
8,367
Medicare Billing
$8.7M
Payment Breakdown by Category
Food & Beverage$3,796 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,796 | 140 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $546.58 | 15 | $0 (2024) |
| Genentech USA, Inc. | $496.19 | 26 | $0 (2024) |
| ABBVIE INC. | $459.07 | 19 | $0 (2024) |
| Allergan, Inc. | $395.71 | 21 | $0 (2020) |
| Astellas Pharma US Inc | $364.85 | 7 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $317.70 | 7 | $0 (2019) |
| Alimera Sciences, Inc. | $239.94 | 9 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $237.99 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $220.36 | 10 | $0 (2022) |
| Aerie Pharmaceuticals, Inc. | $143.87 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $883.69 | 30 | ABBVIE INC. ($258.74) |
| 2023 | $850.65 | 24 | ABBVIE INC. ($200.33) |
| 2022 | $187.79 | 10 | Bausch & Lomb Americas Inc. ($63.87) |
| 2021 | $269.30 | 11 | Regeneron Healthcare Solutions, Inc. ($156.45) |
| 2020 | $198.38 | 7 | Novartis Pharmaceuticals Corporation ($118.06) |
| 2019 | $487.50 | 22 | Bausch & Lomb, a division of Bausch Health US, LLC ($212.74) |
| 2018 | $638.52 | 23 | Genentech USA, Inc. ($175.71) |
| 2017 | $279.91 | 13 | Allergan Inc. ($109.72) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: EYE CARE | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Ophthalmology | ||||||
| 11/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: EYE CARE | ||||||
| 11/12/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/06/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: EYE CARE | ||||||
| 10/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: EYE CARE | ||||||
| 10/22/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: EYE CARE | ||||||
| 10/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: EYE CARE | ||||||
| 10/16/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: EYE CARE | ||||||
| 09/26/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: EYE CARE | ||||||
| 08/13/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: EYE CARE | ||||||
| 08/07/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Ophthalmology | ||||||
| 07/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Ophthalmology | ||||||
| 07/08/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: EYE CARE | ||||||
| 06/26/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: OPTOMETRY | ||||||
| 06/19/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: EYE CARE | ||||||
| 06/03/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $121.58 | General |
| Category: Ophthalmology | ||||||
| 05/23/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: EYE CARE | ||||||
| 05/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Ophthalmology | ||||||
| 05/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/25/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: EYE CARE | ||||||
| 04/19/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Ophthalmology | ||||||
| 04/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,131 | 5,995 | $2.6M | $772,836 |
| 2022 | 12 | 1,487 | 5,576 | $4.7M | $1.5M |
| 2021 | 12 | 2,251 | 12,340 | $9.4M | $3.1M |
| 2020 | 18 | 3,498 | 14,736 | $9.5M | $3.3M |
Total Patients
8,367
Total Services
38,647
Medicare Billing
$8.7M
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 78 | 796 | $1.5M | $532,615 | 35.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 13 | 2,580 | $269,220 | $74,515 | 27.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 134 | 665 | $467,400 | $59,308 | 12.7% |
| 92134 | Imaging of retina | Office | 2023 | 257 | 880 | $88,000 | $25,615 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 235 | $51,700 | $22,138 | 42.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 73 | 321 | $52,002 | $17,482 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 138 | 138 | $38,640 | $16,258 | 42.1% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 12 | 12 | $27,000 | $10,676 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 52 | $8,060 | $2,844 | 35.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $6,800 | $2,704 | 39.8% |
| 92250 | Photography of the retina | Office | 2023 | 87 | 97 | $12,125 | $2,557 | 21.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 22 | 22 | $6,160 | $2,160 | 35.1% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 11 | 13 | $27,300 | $1,963 | 7.2% |
| 67515 | Injection of drug or substance into membrane covering eyeball | Office | 2023 | 23 | 26 | $2,730 | $858.04 | 31.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 24 | $2,760 | $550.99 | 20.0% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 12 | 13 | $3,380 | $511.43 | 15.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 104 | $6,888 | $80.24 | 1.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 172 | 1,342 | $2.5M | $959,681 | 37.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 98 | 1,553 | $1.1M | $363,851 | 33.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 386 | 1,015 | $798,000 | $76,606 | 9.6% |
| 92134 | Imaging of retina | Office | 2022 | 460 | 1,102 | $109,950 | $25,216 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 104 | 104 | $29,120 | $12,917 | 44.4% |
| J3590 | Unclassified biologics | Office | 2022 | 83 | 212 | $34,191 | $8,636 | 25.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 32 | 81 | $13,122 | $4,422 | 33.7% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2022 | 15 | 15 | $31,500 | $2,615 | 8.3% |
About Dr. James Kim, MD
Dr. James Kim, MD is a Ophthalmology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2010. The National Provider Identifier (NPI) number assigned to this provider is 1255657151.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Kim, MD has received a total of $3,796 in payments from pharmaceutical and medical device companies, with $883.69 received in 2024. These payments were reported across 140 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,796).
As a Medicare-enrolled provider, Kim has provided services to 8,367 Medicare beneficiaries, totaling 38,647 services with total Medicare billing of $8.7M. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Fort Wayne, IN
- Active Since 04/16/2010
- Last Updated 08/05/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1255657151
Products in Payments
- LUMIGAN (Drug) $489.25
- Izervay (Drug) $364.85
- OZURDEX (Drug) $337.99
- Syfovre (Drug) $237.99
- EYLEA HD (Biological) $236.80
- EYLEA (Biological) $226.14
- Lucentis (Biological) $203.68
- YUTIQ (Drug) $202.03
- BEOVU (Drug) $159.10
- Vabysmo (Drug) $155.01
- Rhopressa (Drug) $129.06
- VYZULTA (Drug) $126.45
- LOTEMAX SM (Drug) $110.08
- ZYLET (Drug) $96.83
- PanOptix (Device) $84.68
- EYLEA AFLIBERCEPT INJECTION (Biological) $83.64
- BIOTRUE ONE DAY (Device) $63.87
- BESIVANCE (Drug) $44.47
- VABYSMO (Drug) $43.79
- ILUVIEN (Drug) $42.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Fort Wayne
Jonathan Walker, M.d, M.D
Ophthalmology — Payments: $9,428
Ophthalmology $9,428
Dr. John Parent, M.d, M.D
Ophthalmology — Payments: $4,115
Ophthalmology $4,115
Anne Krafsig, Md, MD
Ophthalmology — Payments: $4,004
Ophthalmology $4,004
Dr. Adeel Khan, M.d, M.D
Ophthalmology — Payments: $3,587
Ophthalmology $3,587
Dr. Randal Hughes, Md, MD
Ophthalmology — Payments: $3,557
Ophthalmology $3,557
Barbara Schroeder, M.d, M.D
Ophthalmology — Payments: $3,381
Ophthalmology $3,381